Serum miR-663 expression and the diagnostic value in colorectal cancer

12Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Colorectal cancer (CRC) is one of the most common digestive cancers leading to deaths worldwide. In this study, we aimed to investigate the diagnostic value of miR-663 in CRC. The expression of miR-663 was detected by quantitative real-time reverse transcriptase-polymerase chain reaction (qRT-PCR). The association between miR-663 and clinical parameters of subjects was evaluated by chi-square test. Additionally, ROC (receiver operating characteristic) analysis was performed to evaluate the diagnostic role of miR-663 in CRC. The expression of miR-663 in CRC patients was significantly upregulated compared with benign colorectal disease patients and healthy controls (p

Cite

CITATION STYLE

APA

Wang, N., Zeng, L., Li, Z., Zhen, Y., & Chen, H. (2019). Serum miR-663 expression and the diagnostic value in colorectal cancer. Artificial Cells, Nanomedicine and Biotechnology, 47(1), 2650–2653. https://doi.org/10.1080/21691401.2019.1628036

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free